TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
3,557,767
|
3,059,082
|
1,639,157 |
Financial expenses |
143,851
|
112,564
|
10,481 |
Earnings before taxes |
-3,760,374
|
507,955
|
448,572 |
EBITDA |
1,131,556
|
993,208
|
495,370 |
Total assets |
16,541,795
|
19,439,451
|
18,947,393 |
Current assets |
1,938,943
|
1,487,921
|
1,371,749 |
Current liabilities |
564,259
|
587,412
|
930,680 |
Equity capital |
12,887,790
|
15,830,794
|
14,942,525 |
- share capital |
28,365
|
26,486
|
26,946 |
Employees (average) |
1,084
|
1,117
|
478 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
77.9%
|
81.4%
|
78.9% |
Turnover per employee |
3,282
|
2,739
|
3,429 |
Profit as a percentage of turnover |
-105.7%
|
16.6%
|
27.4% |
Return on assets (ROA) |
-21.9%
|
3.2%
|
2.4% |
Current ratio |
343.6%
|
253.3%
|
147.4% |
Return on equity (ROE) |
-29.2%
|
3.2%
|
3.0% |
Change turnover |
281,623
|
1,469,188
|
424,448 |
Change turnover % |
9%
|
92%
|
35% |
Chg. No. of employees |
-33
|
639
|
73 |
Chg. No. of employees % |
-3%
|
134%
|
18% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.